American Vanguard NYSE: AVD reported lower second-quarter sales amid challenging agricultural market conditions, while management said U.S. specialty growth, cost actions and product-development investments supported its full-year outlook.
American Vanguard Corporation (AVD) Q2 2026 Earnings Call Transcript
American Vanguard Corporation ( AVD ) Q3 2025 Earnings Call November 10, 2025 9:00 AM EST Company Participants Anthony Young - Director of Investor Relations Douglas Kaye - Chairman & CEO David Johnson - Chief Financial Officer Conference Call Participants Michael Harrison - Seaport Research Partners Wayne Pinsent - The Gabelli Healthcare & Wellness Trust Charles Rose Dmitry Silversteyn - Water Tower Research LLC Presentation Operator Greetings, and welcome to the American Vanguard Third Quarter 2025 Earnings Conference Call. [Operator Instructions] And please note, this conference is being recorded.
| Chemicals Industry | Materials Sector | Douglas A. Kaye CEO | XFRA Exchange | 030371108 CUSIP |
| US Country | 739 Employees | 10 Jul 2024 Last Dividend | 18 Apr 2006 Last Split | - IPO Date |
American Vanguard Corporation, rooted in its operation since 1969, stands as a significant player in the chemical manufacturing industry, with a focus on serving the agricultural sector, alongside commercial and consumer markets both in the United States and globally. With its headquarters in Newport Beach, California, the company is engaged in the development, manufacture, and marketing of specialized chemicals that are instrumental in addressing a wide range of needs. From farming to consumer health protection, American Vanguard’s operations span across a multifaceted spectrum, ensuring a comprehensive approach towards chemical solutions.